Eric Watsky

931 total citations
16 papers, 692 citations indexed

About

Eric Watsky is a scholar working on Psychiatry and Mental health, Rheumatology and Philosophy. According to data from OpenAlex, Eric Watsky has authored 16 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 5 papers in Rheumatology and 4 papers in Philosophy. Recurrent topics in Eric Watsky's work include Schizophrenia research and treatment (6 papers), Mental Health and Psychiatry (4 papers) and Multiple Sclerosis Research Studies (2 papers). Eric Watsky is often cited by papers focused on Schizophrenia research and treatment (6 papers), Mental Health and Psychiatry (4 papers) and Multiple Sclerosis Research Studies (2 papers). Eric Watsky collaborates with scholars based in United States, Canada and Italy. Eric Watsky's co-authors include Karen R. Reeves, John J. Sramek, Thomas Shiovitz, Jeffrey Miceli, Richard Anziano, Edmund P. Harrigan, Michelle V. Middle, Neal R. Cutler, Steven G. Potkin and Cynthia Siu and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Bone.

In The Last Decade

Eric Watsky

16 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Watsky United States	12	260	160	143	129	104	16	692
Morten Charles Denmark	20	162 0.6×	106 0.7×	377 2.6×	203 1.6×	20 0.2×	45	1.3k
Vittorio Bocola Italy	9	302 1.2×	159 1.0×	186 1.3×	110 0.9×	29 0.3×	13	1000
Elisabeth M. C. Schrijvers Netherlands	10	420 1.6×	213 1.3×	115 0.8×	81 0.6×	37 0.4×	12	1.2k
Matthew A. Fuller United States	18	570 2.2×	51 0.3×	131 0.9×	39 0.3×	26 0.3×	52	835
Emmanuelle Duron France	18	230 0.9×	102 0.6×	92 0.6×	308 2.4×	37 0.4×	56	1.0k
Albert Hofman Netherlands	13	235 0.9×	156 1.0×	75 0.5×	76 0.6×	26 0.3×	31	1.1k
G Göthberg Sweden	22	68 0.3×	114 0.7×	173 1.2×	316 2.4×	221 2.1×	59	1.5k
Torbjörn Lindström Sweden	22	83 0.3×	205 1.3×	557 3.9×	235 1.8×	13 0.1×	57	1.3k
Tonya Marmon United States	11	109 0.4×	60 0.4×	54 0.4×	46 0.4×	9 0.1×	40	802
René Swanink United States	12	839 3.2×	81 0.5×	75 0.5×	13 0.1×	60 0.6×	20	1.3k

Countries citing papers authored by Eric Watsky

Since Specialization

Citations

This map shows the geographic impact of Eric Watsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Watsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Watsky more than expected).

Fields of papers citing papers by Eric Watsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Watsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Watsky. The network helps show where Eric Watsky may publish in the future.

Co-authorship network of co-authors of Eric Watsky

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Watsky. A scholar is included among the top collaborators of Eric Watsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Watsky. Eric Watsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Seefried, Lothar, Priya S. Kishnani, Scott Moseley, et al.. (2020). Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia. Bone. 142. 115664–115664. 30 indexed citations

Kishnani, Priya S., Cheryl R. Greenberg, Frank Rauch, et al.. (2018). Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 121. 149–162. 110 indexed citations

Watsky, Eric, Nelly A. Kuklin, M. Hamilton, & Sharon Barr. (2017). Maintenance of disease-relevant biomarker improvement in patients with Molybdenum Cofactor Deficiency (MoCD) Type A administered ALXN1101, a synthetic form of cyclic pyranopterin monophosphate. European Journal of Paediatric Neurology. 21. e124–e124. 2 indexed citations

Klamerus, Karen J., et al.. (2014). The effect of tafamidis on the QT_c interval in healthy subjects. British Journal of Clinical Pharmacology. 79(6). 918–925. 16 indexed citations

Agid, Ofer, Cynthia Siu, Steven G. Potkin, et al.. (2013). Meta-Regression Analysis of Placebo Response in Antipsychotic Trials, 1970–2010. American Journal of Psychiatry. 170(11). 1335–1344. 107 indexed citations

Singer, B., Sibyl Wray, Tamara Miller, et al.. (2012). Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders. 1(2). 87–94. 14 indexed citations

Potkin, Steven G., Ofer Agid, Cynthia Siu, et al.. (2011). Placebo response trajectories in short-term and long-term antipsychotic trials in schizophrenia. Schizophrenia Research. 132(2-3). 108–113. 20 indexed citations

Wray, Sibyl, Robert W. Armstrong, Craig Herrman, et al.. (2011). Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study. Expert Opinion on Drug Delivery. 8(12). 1543–1553. 17 indexed citations

Stahl, Stephen M., Ashok Malla, John W. Newcomer, et al.. (2010). A Post Hoc Analysis of Negative Symptoms and Psychosocial Function in Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 30(4). 425–430. 22 indexed citations

10.

Agid, Ofer, Steven G. Potkin, Gary Remington, et al.. (2010). PLACEBO RESPONSE IN ANTIPSYCHOTIC TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Schizophrenia Research. 117(2-3). 492–492. 1 indexed citations

11.

Potkin, Steven G., Peter J. Weiden, Antony Loebel, et al.. (2009). Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol. The International Journal of Neuropsychopharmacology. 12(9). 1233–1233. 34 indexed citations

12.

Reus, Victor I., R. Scott Obach, Jotham W. Coe, et al.. (2007). Varenicline: New treatment with efficacy in smoking cessation. Drugs of today. 43(2). 65–65. 31 indexed citations

13.

Harrigan, Edmund P., Jeffrey Miceli, Richard Anziano, et al.. (2004). A Randomized Evaluation of the Effects of Six Antipsychotic Agents on QTc, In the Absence and Presence of Metabolic Inhibition. Journal of Clinical Psychopharmacology. 24(1). 62–69. 258 indexed citations

14.

Breier, Alan, Richard Coppola, Igor Elman, et al.. (1996). D2 Receptor occupancy in risperidone and clozapine-treated schizophrenics. Biological Psychiatry. 39(7). 513–514. 8 indexed citations

15.

Jimerson, David C., et al.. (1993). Response to SSRI antidepressants correlates with reduction in plasma HVA: Pilot study. Biological Psychiatry. 34(8). 569–571. 12 indexed citations

16.

Watsky, Eric & Carl Salzman. (1991). Psychotropic Drug Interactions. Psychiatric Services. 42(3). 247–256. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact